BioengineeringbioRxivPreprint
MRI-Trackable Mesenchymal Stem Cells for Oncolytic Therapy: A Clinically Feasible Dual-Labeling Protocol
Harshan Ravi, Deborah R. Healey, Neha Damodar…·C. Chad Quarles
This study evaluates a dual-labeling protocol for mesenchymal stem cells with iron oxide particles and an oncolytic virus, showing preserved cellular function and MRI detectability.